SCHEMBL7130494

SCHEMBL7130494

O=C1Nc2c(Br)cc(Br)cc2C1=Cc1ccnc2ccccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 2/20 0.38
CHEK1 O14757 1/20 0.38
RET P07949 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
NTRK1 P04629 4/20 0.36
RAF1 P04049 2/20 0.36
MEN1 O00255 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 1/20 0.36
CASP3 P42574 1/20 0.36
HTT P42858 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
ACVR1 Q04771 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
ALOX15 P16050 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7139579 0.80 RET (0.38) CYP11B2RETTDP1NTRK1RAF1
SCHEMBL5365774 0.79 IKBKB (0.41) RAF1MEN1ALDH1A1MAPTKMT2A
SCHEMBL6291705 0.78 PARP1 (0.47) CYP11B2CHEK1RETTDP1NTRK1
SCHEMBL6291703 0.78 PARP1 (0.47) CYP11B2CHEK1RETTDP1NTRK1
SCHEMBL5728224 0.77 CHEK1 (0.60) CHEK1RETTDP1NTRK1MEN1
SCHEMBL5728227 0.77 CHEK1 (0.60) CHEK1RETTDP1NTRK1MEN1
SCHEMBL15503691 0.77 CHEK1 (0.60) CHEK1RETTDP1NTRK1MEN1
SCHEMBL5363068 0.76 GSK3B (0.51) RAF1MEN1ALDH1A1MAPTKMT2A
SCHEMBL22409625 0.76 KMT2A (0.51) CYP11B2TDP1MEN1ALDH1A1MAPT
SCHEMBL8529758 0.76 PDPK1 (0.52) CHEK1RETTDP1NTRK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506763-B2 Useful in prevention and treatment of protein kinase related disorders such as cancer SUGEN, INC. 2003-01-14 US disclosed